Expert Care for Thyroid Cancer

Step into the world of Dr. Mahamed Shama and the Tulane Thyroid Cancer Center, where our dedicated focus is on thyroid cancer cases and suspicious thyroid masses. Our commitment extends to all types of thyroid cancer recurrences, especially those considered unresectable by others.

Dr. Shama’s unparalleled expertise unfolds in the meticulous preservation of the vocal nerve during recurrent cancer surgeries, employing cutting-edge Microscopic Surgery techniques.

While we deeply acknowledge the significance of the initial surgery as the prime opportunity for a cure, our unwavering commitment with Dr. Shama at Tulane Thyroid Cancer Center is dedicated to diligently providing recurrent cancer patients with a second chance for a successful cure.

Your journey of resilience commences right here at Tulane Thyroid Cancer Center.

Tulane Doctor Emad Kandil

Dr. Mohamed Shama

Dr. Shama is an esteemed Assistant Professor of Endocrine Surgery at Tulane University Medical School in New Orleans, LA. He earned his MD from Cairo University School of Medicine in 2002 and has since built a distinguished career in surgical oncology.

Dr. Shama spent nearly a decade at the National Cancer Institute, the largest cancer center in the Middle East, where he honed his skills in teaching and clinical practice. He also gained invaluable experience at Chung Gung Memorial Hospital in Taiwan, one of the leading Head and Neck Cancer Centers in the Far East.

After moving to the United States, Dr. Shama completed a year of research at the renowned MD Anderson Cancer Center. He then pursued a clinical fellowship in Thyroid and Parathyroid Surgery at Harvard Medical School, followed by two years of specialized training in complex Head and Neck Cancer Surgery and Microvascular Reconstruction through accredited AHNS fellowships at the University of Florida and Henry Ford Hospital in Detroit.

Upon completing his extensive training, Dr. Shama joined Tulane University as a full-time attending physician. He is a passionate mentor and a sought-after educator among medical students, residents, and fellows.

Dr. Shama is a member of the Royal College of Surgeons of England (2008) and holds board certification in Surgical Oncology from the European Society of Surgical Oncology (2014)

Dr. Shama has been an independent Head and Neck Cancer Surgeon specializing in thyroid cancer for over 12 years.

Certifications:

  • European Board of Surgery Qualification in Surgical Oncology (EBSQ), 2014
  • Master of General Surgery, Cairo University, Egypt (MSc), 2013
  • ECFMG Certificate, 2009
  • Member of the Royal College of Surgeons of England (MRCS), 2008

Doctors and patients need a well coordinated plan to fight thyroid cancer.

Expertise, Research & Publications

PEER-REVIEWED JOURNAL ARTICLES:

  • Total Thyroidectomy Versus Lobectomy in Small Nodules Suspicious for Papillary Thyroid Cancer: Cost-Effectiveness Analysis. Al-Qurayshi Z, Farag M, Shama MA, Ibraheem K, Randolph GW, Kandil E. Laryngoscope 2020 Dec.
  • Asthma in COVID-19 patients: An extra chain fitting around the neck? Mohammad H. Hussein, Eman A. Toraih, Abdallah S. Attia, Nicholas Burley, Allen D. Zhang, Jackson
    Roos, August Houghton, Nedum Aniemeka, Mahmoud Omar, Mohamed
    Aboueisha,     Mohamed A. Shama, Juan Duchesne, and Emad Kandil. Respiratory Medicine 2020 Dec.
  • Comparison of Recording Electrode Arrays in Endotracheal Thyroid Monitoring Tubes in a Porcine Model: Kandil E, Al-Qurayshi Z, Randolph G, Shama M, Bamford J, Kang SW. Tulane University, LA, USA; Laryngoscope 2020 Jan.
  • Beavertail modification of the radial forearm free flap in total oral glossectomy reconstruction: Technique and functional outcomes. Peter T. Dziegielewski, Jana Rieger, Mohamed A. Shama, Daniel A. O’Connell, Jeffrey R. Harris, Hadi Seikaly. University of Florida, Gainesville, FL, USA; Oral Oncology- 2019 July.
  • Tongue Reconstruction: Rebuilding Mobile Three Dimensional Structures from Immobile Two Dimensional Substrates, a Fresh Cadaver Study. Michael Baskin, Hadi Seikaly, Raja Sawhney, Deepa Danan, Martha Burt, Sherif Idris, Mohamed Shama, Brian Boyce, Peter T. Dziegielewski. University of Florida, Gainesville, FL, USA; Head and Neck- 2019 July.
  • Minimal Extrathyroidal Extension does not affect Survival of Well-differentiated Thyroid Cancer. Mohamed A. Shama, Zaid Qurayshi, Gregory W. Randolph, Emad Kandil. Tulane University, LA – Massachusetts Eye and Ear/Harvard Medical School, MA, USA; Endocrine Related Cancer 2017 May.
  • Safety and reliability of a handheld stimulator for neural monitoring during thyroid surgery. Bradley R. Lawson, Dipti Kamani, Mohamed Shama, Natalia Kyriazidis, Gregory W. Randolph. Massachusetts Eye and Ear/Harvard Medical School, MD, USA; Laryngoscope 2019 Apr.
  • Anterior laryngeal electrodes for recurrent laryngeal nerve monitoring during thyroid and parathyroid surgery: New expanded options for neural monitoring. Liddy W, Lawson BR, Barber SR, Kamani D, Shama M, Soylu S, Wu CW, Chiang FY, Scharpf J, Barczynski M, Dralle H, Van Slycke S, Schneider R, Dionigi G, Randolph GW. Massachusetts Eye and Ear/Harvard Medical School, MA, USA; Laryngoscope 2018 Nov.
  • Association of diabetes with perineural invasion in pancreatic cancer. Sahin IH, Shama MA, Tanaka M, Abbruzzese JL, Curley SA, Hassan M, Li D.; The University of Texas M. D. Anderson Cancer Center, Houston, TX; Cancer Medicine 2012 Dec.
  • Treatment outcome and prognostic indicators in 94 cases of fibrolamellar hepatocellular carcinoma. Ahmed O Kaseb, Mohamed Shama, Ibrahim Halil Sahin, Ajay Nooka, Hesham M Hassabo, Jean-Nicolas Vauthey, Thomas Aloia, James L Abbruzzese, Ishwaria M Subbiah, Filip Janku, Steven Curley, Manal M Hassan.; The University of Texas M. D. Anderson Cancer Center, Houston, TX; Oncology 2013
  • Genetic variation in the PNPLA3 gene and hepatocellular carcinoma in USA: Risk and prognosis prediction. Hassan MM, Kaseb A, Etzel CJ, El-Serag H, Spitz MR, Chang P, Hale KS, Liu M, Rashid A, Shama M, Abbruzzese JL, Loyer EM, Kaur H, Hassabo HM, Vauthey JN, Wray CJ, Hassan BS, Patt YZ, Hawk E, Soliman KM, Li D; The University of Texas M. D. Anderson Cancer Center, Houston, TX; Molecular Carcinogenesis 2013 Jun.
  • Prognosis of Fibrolamellar Carcinoma Compared to Non-cirrhotic Conventional Hepatocellular Carcinoma. Yamashita S, Vauthey JN, Kaseb AO, Aloia TA, Conrad C, Hassan MM, Passot G, Raghav KP, Shama MA, Chun YS; The University of Texas M. D. Anderson Cancer Center, Houston, TX; J Gastrointest Surg-2016 Oct.